November 5, 2020Open Access
Inflammation in Atherosclerosis—No Longer a Theory
Key Points
Key points are not available for this paper at this time.
Abstract
Much work remains to optimize further anti-inflammatory interventions, minimize unwanted actions, and refine patient selection. This long road from discovery in the laboratory to successful clinical trials represents a victory for medical science, and opens a new avenue to reducing the risk that remains despite current treatments for atherosclerosis.
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Cite this study
Peter Libby (Thu,) studied this question.
synapsesocial.com/papers/69d88fe0e9c100a435ae2d74 — DOI: https://doi.org/10.1093/clinchem/hvaa275
Authors
Peter Libby
Preventive Cardiology
Journals
Clinical Chemistry
Actions
Institutions
Harvard University
Brigham and Women's Hospital
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...